Spinal Stenosis Lumbar Clinical Trial
— GetBackOfficial title:
Get Back, a Person-centred Digital Program Targeting Physical Activity for Patients Undergoing Spinal Stenosis Surgery - a Randomized Feasibility Study
NCT number | NCT05806593 |
Other study ID # | Get Back |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 17, 2023 |
Est. completion date | October 2024 |
Spinal stenosis is the most common cause of degenerative spinal surgery. The majority do not achieve the global recommendations for health-promoting physical activity before or after surgery. Patients with a low level of physical activity and a high degree of fear of movement are at an increased risk of poorer health outcomes after surgery. Increasing the number of steps per day is a way to increase physical activity, which in long term can lead to health benefits. In addition, a digital format is a way to increase the availability of physiotherapy to strive for equal rehabilitation. The overall purpose of the research project is to improve health outcome and increase the availability of rehabilitation for patients at high risk of negative health outcomes after spinal surgery due to spinal stenosis through Get Back, a person-centered and digital program with a focus on physical activity. Before conducting a large-scale study, the investigators want to conduct a study that aims to investigate and develop the Get Back program regarding content and dose, treatment fidelity as well as feasibility in terms of study procedure, compliance, and acceptability. Approximately thirty patients with lumbar spinal stenosis and an identified risk profile for poorer postoperative outcomes will be recruited from two spine clinics in Sweden. The program involves meeting a physiotherapist digitally (through video call) approximately 1 week before surgery to formulate a person-centered health plan. The health plan is monitored and progressed by the physiotherapist by video until eleven weeks after surgery. The Get Back program includes 5 sessions (1 hour each) which are supplemented with 5 booster sessions (30 minutes) to reinforce the intervention. Get Back is based on three key components that run through all sessions. These are person-centeredness, behavioral medicine techniques to reduce fear of movement and worries about pain, as well as to optimize physical activity. The physiotherapist supports the participant's individual resources and abilities through validated behavioral medicine methods in combination with education/communication/knowledge support and behavior-strengthening tools (which are also used in-between sessions) to achieve the participant's personal goals linked to physical functioning, physical activity, and health. The program will be compared to standard physiotherapy.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | October 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients planned for decompression surgery (no fusion) due to central lumbar spinal stenosis - reporting a low level of physical activity (do not meet WHO´s physical activity recommendations of minimum 150 min moderate intensity per week), and one of the following criteria at preoperative screening; fear of movement (Tampa Scale of Kinesiophobia (TSK) = 37) and/or pain catastrophizing (Pain Catastrophizing Scale (PCS) >30). Exclusion Criteria: - Patients with malignancy, severe neurological -or rheumatic disease, idiopathic scoliosis, isthmic spondylolisthesis - not able to understand written information and communicate in Swedish |
Country | Name | City | State |
---|---|---|---|
Sweden | Ryggkirurgiskt centrum Stockholm | Stockholm | |
Sweden | Capio Spine Center Göteborg | Västra Frölunda | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Sophiahemmet University | AFA Insurance, The Swedish Research Council |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in variables related to intervention content. | A questionnaire including 14 one-item questions aiming to capture steps per day (reported from a pedometer), self-reported physical activity level, and relevant aspects of pain catastrophizing, fear of movement and self-efficacy (on rating scales ranging from 0 to 10). | Once a week during the 12-week study period. | |
Primary | The intervention participants frequency and length of contact with the study physiotherapist. | The data will be noted by the study physiotherapist on each session protocol. | Continuously during the 12 week intervention. | |
Primary | Checklist of included components at each treatment session. | The treatment components addressed during each intervention session will be noted by the study physiotherapist on a checklist. | Continuously during the 12 week intervention. | |
Primary | Analysis of audio recordings from the intervention sessions. | Audio recordings of the intervention sessions will be conducted and transcribed for post-hoc analysis by a third party (trained in person centredness and cognitive behavioural therapy) to ensure that the key components of the intervention are included. | Continuously during the 12 week intervention. | |
Primary | Type and frequency of possible adverse events. | The type and frequency of possible adverse events during the intervention will be collected by the study physiotherapist and noted on each session protocol. | Continuously during the 12 week intervention. | |
Primary | Percentage of patients eligible after the screening procedure. | The data will be noted on screeninglists. | Through study completion, an average of 6 month. | |
Primary | Number of intervention sessions attended out of planned. | The data will be noted by the study physiotherapist on each session protocol. | Through study completion for each intervention participant, an average of 12 weeks. | |
Primary | Acceptability of data collection methods measured with a study specific questionnaire. | Study specific questionnaires including questions related to experiences from participants and assessors of the methods used for data collection. | At the end of each participants 12 week study period. | |
Primary | Participants experiences of the intervention collected via telephone interviews. | Semi structured telephone interviews with participants of the intervention group, which will be audio recorded and transcribed into text material. | At the end of intervention/after 12 weeks. | |
Secondary | Steps per day collected with a activity tracker/accelerometer (Actigraph GT3X+). | Reported as number of steps per day. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Physical activity level collected with a activity tracker/accelerometer (Actigraph GT3X+). | Reported as time spent in light physical activity, moderate to vigorous physical activity (MVPA) and time spent sedentary. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Physical function measured with the Timed-up-and-go test (TUG). | The time it takes for a participant to rise from a chair, walk 3 meters, turn, walk back to the chair and sit down. Reported in seconds. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Postural balance measured with the One Leg Stand test. | The time a participant can stand on one leg, reported in seconds. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Functional leg strength measured with the 30 seconds sit-to-stand test. | Reported as the number of chair rises a participant can complete during 30 seconds. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Self-reported physical activity collected with a two-item questionnaire from the National Board of Health and Welfare in Sweden. | The results are presented as reaching or not reaching 150 minutes of moderate physical activity per week. | At baseline, and post-intervention/after 12 weeks | |
Secondary | The person's own goals regarding function collected with the Patient Specific Functional Scale (PSFS). | The participant will choose three activities of individual importance and rate the ability to perform each activity on a scale from 0 (not able to perform the activity) to 10 (can perform the activity unhindered). | At baseline, and post-intervention/after 12 weeks | |
Secondary | Health related quality of life collected with the EuroQol five dimension scale (EQ-5D 3L). | Reported as an index utility score between 0 to 1 (a higher score indicates better health state) and a visual analogue scale of self-related overall health ranging from 0 to 100 (a higher score indicates better overall health). | At baseline, and post-intervention/after 12 weeks | |
Secondary | Self-reported disability collected with the Oswestry Disability Index (ODI). | Score range from 0 to 50. Higher scores represent greater disability. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Depressed mood collected with the depression subscale of the Hospital Anxiety and Depression Scale. | Score range from 0 to 21. A score of 8 or more indicated depression. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Pain intensity level in the leg and back reported with the Numeric Rating Scale (NRS). | On a scale from 0 to 10, where a higher reported number means higher pain intensity. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Catastrophizing thoughts related to pain collected with the Pain Catastrophizing Scale (PCS). | Score range from 0 to 52. Higher scores mean higher degree of catastrophizing thoughts related to pain. | At baseline, and post-intervention/after 12 weeks | |
Secondary | Patient-reported kinesiophobia collected with the Swedish version of the Tampa Scale of Kinesiophobia (TSK-SV). | Score range from 17 to 68. Higher scores mean higher degree of fear of movement. | At baseline, and post-intervention/after 12 weeks | |
Secondary | General self-efficacy collected with the General Self-efficacy Scale (GSE). | Score range from 10 to 40. Higher scores mean higher self-efficacy. | At baseline, and post-intervention/after 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02555280 -
Coflex PS3 Actual Conditions for Use Study
|
N/A | |
Completed |
NCT05548608 -
Lumbar Proprioception in Patients With Lumbar Spinal Stenosis
|
||
Completed |
NCT05619848 -
Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery
|
Early Phase 1 | |
Recruiting |
NCT04401735 -
Effects and Safety of Epidural PDRN vs. Placebo
|
Phase 4 | |
Recruiting |
NCT03105167 -
Cortical Bone Trajectory Screws vs. Traditional Pedicle Screws Fixation
|
N/A | |
Completed |
NCT03495661 -
Decompression vs Physical Training for the Treatment of Lumbar Spinal Stenosis
|
N/A | |
Not yet recruiting |
NCT06367855 -
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF : Double Blinded, Randomized Control Trial
|
Phase 4 | |
Recruiting |
NCT05253326 -
The Effect of Progressive Muscle Relaxation Exercises on Pain and Disability After Spinal Surgery
|
N/A | |
Completed |
NCT04058171 -
Validation of a Treadmill Walking Test to Discriminate Neurogenic Claudication From Vascular Claudication
|
||
Withdrawn |
NCT02982291 -
Focused Spinal Stenosis Rehabilitation Program for Lumbar Spinal Stenosis
|
N/A | |
Completed |
NCT03863769 -
Chiropractic Distraction Spinal Manipulation- Lumbar Stenosis Study
|
||
Completed |
NCT03538093 -
Lumbar Stabilization Exercises in Adult Patients With Lumbar Arthrodesis Surgery
|
N/A | |
Not yet recruiting |
NCT04447950 -
Randomized Control Trial of Quadratus Lumborum Block for Lumbar Spine Decompression and Fusion Surgery
|
N/A | |
Completed |
NCT04443738 -
Long Term Follow up of Spinal Stenosis Inpatients Treated With Korean Integrative Medicine Treatment.
|
||
Not yet recruiting |
NCT05297513 -
Efficacy of ActiveMatrix on Spinal SSI Rate
|
Phase 4 | |
Active, not recruiting |
NCT04492774 -
Degenerative Lumbar Stenosis Conservative Treatment
|
Phase 4 | |
Not yet recruiting |
NCT03584074 -
Clinical Trial of Pregabalin and COX2 in Spinal Stenosis
|
Phase 4 | |
Completed |
NCT06393959 -
Relief of Lumbar Spinal Stenosis Symptoms
|
N/A | |
Completed |
NCT05161130 -
Predicting Outcomes After Lumbar Fusion for Degenerative Disease
|
||
Completed |
NCT03884283 -
Prospective, Multi-center Study to Assess Posterolateral Fusion Using FIBERGRAFT
|
N/A |